Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine for Supernormal Oxygen Delivery in Severe Burns
NCT05241912Phase 1Unknown
- Sponsor
- Guangzhou Red Cross Hospital
- Start
- Feb 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dobutamine in burn injury (2 arms), sponsored by Guangzhou Red Cross Hospital. Primary endpoint: Complications at 1 week. Status: unknown.
02
Drugs
dobutamine
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT05241912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05241912.